Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update
P Morales, L Hernandez-Folgado, P Goya… - Expert opinion on …, 2016 - Taylor & Francis
Introduction: Modulation of the CB2 receptor is an interesting approach for pain and
inflammation, arthritis, addictions, neuroprotection, and cancer, among other possible …
inflammation, arthritis, addictions, neuroprotection, and cancer, among other possible …
Dose‐dependent cannabidiol‐induced elevation of intracellular calcium and apoptosis in human articular chondrocytes
M Winklmayr, M Gaisberger, M Kittl… - Journal of …, 2019 - Wiley Online Library
Cannabidiol (CBD) is the most abundant non‐psychoactive compound of Cannabis sativa
extracts. Cannabinoids have been shown to exhibit anti‐inflammatory, analgesic …
extracts. Cannabinoids have been shown to exhibit anti‐inflammatory, analgesic …
OP0325 safety and efficacy of lenabasum in an open-label extension of a phase 2 study in diffuse cutaneous systemic sclerosis subjects (DCSSC)
Background Lenabasum is a synthetic, non-immunosuppressive, selective cannabinoid
receptor type 2 agonist that activates resolution of innate immune responses and limits …
receptor type 2 agonist that activates resolution of innate immune responses and limits …
OP0324 CANNABIDIOL ELEVATES INTRACELLULAR CALCIUM AND INDUCES APOPTOSIS IN HUMAN ARTICULAR CHONDROCYTES
Background Osteoarthritis (OA) is a major public health problem among the increasing aged
and obese population, therefore development and investigation of new therapeutics is a …
and obese population, therefore development and investigation of new therapeutics is a …